Analgesics (Pharmacies) - Philippines

Revenue in the Analgesics market is projected to reach US$66.48m in 2024.
Revenue is expected to show an annual growth rate (CAGR 2024-2029) of 8.63%, resulting in a market volume of US$100.60m by 2029.
In global comparison, most revenue will be generated China (US$5.03bn in 2024).
In relation to total population figures, per person revenues of US$0.56 are generated in 2024.

Definition:
The Analgesics market encompasses non-prescription natural and synthetic non-opioid analgesics sold through pharmacies. These include well-known products such as Paracetamol, Ibuprofen, Aspirin, Diclofenac, and various pain-relieving preparations. The market's scope varies with national legislation concerning opioid analgesics, with legal opioids being incorporated based on respective state regulations. In countries like Germany, Austria, and Switzerland, opioid analgesics are included if they comply with narcotics law limitations and do not necessitate a prescription. The analgesics are presented in forms like pills, capsules, gels, and ointments. However, the market excludes prescription medications (e.g., morphine), anesthetics, and homeopathic remedies. Notable top-selling painkillers encompass Voltaren, Aspirin, Thomapyrin, Ibuprofen, Dolormin, Paracetamol, and ASS. This market exclusively covers product sales through pharmacies.

Additional information:
The Analgesics market comprises revenues, average revenue per capita and average revenue per pharmacy. Revenues include VAT. The market only displays B2C revenues, hence B2B and B2G revenues are not included.
For more information on the data displayed, use the info button next to the boxes.

Over-the-counter analgesics (e.g. Aspirin and Paracetamol)
Natural and synthetic agents
In the form of pills, capsules, gels and ointments

Prescription medicines
Homeopathic remedies
Anesthetics

The Analgesics (Pharmacies) market in Philippines is experiencing steady growth due to several factors.

Customer preferences: Customers in the Philippines have a growing preference for over-the-counter analgesics available at pharmacies. This is primarily driven by the convenience and accessibility of these products. Many customers prefer to self-medicate for common ailments such as headaches, muscle pain, and fever, and pharmacies provide a wide range of analgesics to cater to these needs. Additionally, customers in the Philippines tend to trust the advice and recommendations of pharmacists, further driving their preference for purchasing analgesics from pharmacies.

Trends in the market: One of the key trends in the Analgesics market in the Philippines is the increasing demand for natural and herbal analgesics. Customers are becoming more conscious of the potential side effects of synthetic analgesics and are seeking alternative options. As a result, there has been a rise in the availability and popularity of natural and herbal analgesics in pharmacies across the country. This trend is expected to continue as customers prioritize their health and well-being. Another trend in the market is the growing demand for analgesics specifically formulated for different age groups. Customers in the Philippines are increasingly looking for analgesics that are safe and effective for children, the elderly, and pregnant women. This has led to the development of specialized analgesics targeting these specific customer segments. Pharmacies are stocking a wider variety of these specialized analgesics to cater to the diverse needs of their customers.

Local special circumstances: The Philippines has a large population with a significant portion living in rural areas. Access to healthcare facilities, including pharmacies, can be limited in these areas. As a result, there is a growing demand for mobile pharmacies and online pharmacies that can deliver analgesics directly to customers' homes. This trend is particularly evident in rural areas where customers may have to travel long distances to reach a pharmacy. Pharmacies in the Philippines are adapting to this demand by expanding their online presence and offering home delivery services.

Underlying macroeconomic factors: The growing economy in the Philippines is contributing to the development of the Analgesics market. As disposable incomes rise, customers have more purchasing power to spend on healthcare products, including analgesics. Additionally, the increasing urbanization and changing lifestyles in the country are leading to higher stress levels and a greater need for pain relief, further driving the demand for analgesics. The government's focus on improving healthcare infrastructure and access to healthcare services also plays a role in the market's growth. In conclusion, the Analgesics (Pharmacies) market in the Philippines is experiencing steady growth due to customer preferences for over-the-counter analgesics, the increasing demand for natural and specialized analgesics, the need for mobile and online pharmacies in rural areas, and the underlying macroeconomic factors such as rising disposable incomes and changing lifestyles.

Data coverage:

The data encompasses B2C enterprises. Figures are based on offline and online spending by consumers, including VAT. Not included are B2B and B2G sales, or other pharmaceutical sales through hospitals or retail stores such as supermarkets.

Modeling approach:

Market sizes are determined through a bottom-up approach, building on specific predefined factors for each market market. As a basis for evaluating markets, we use industry associations, third-party studies and reports and survey results from our primary research (e.g., the Statista Global Consumer Survey). In addition, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per country, consumer healthcare spending, GDP and internet penetration. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the relevant market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. For forecasting digital trends such as the online-pharmacy sales share we use exponential trend smoothing and the s-curve method. The main drivers are healthcare expenditure per country and consumer healthcare spending.

Additional notes:

The data is modeled using current exchange rates. The impact of the COVID-19 pandemic and the Russia-Ukraine war are considered at a country-specific level. The market is updated twice a year. GCS data is reweighted for representativeness.

This report presents a comprehensive analysis and additional information on the Health market, in a PDF format.

The global online pharmacy sector was estimated at 32 billion U.S. dollars by the end of 2023. In the United States, forecasts indicate that this figure would reach approximately 5.7 billion, solidifying its position as one of the largest online pharmacy markets. However, China dominates the pharma e-commerce industry worldwide, generating nearly 8.5 billion dollars in revenue. With China at the forefront, it is no wonder digital pharmacies make up the fastest-growing segment in the Asian digital health market.